Sandbox: sadaf: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
Ssharfaei (talk | contribs)
Line 31: Line 31:
<br style="clear:left" />
<br style="clear:left" />
<br style="clear:left" />
<br style="clear:left" />
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
 
{| style="border: 0; float: left; width: 45%; position: float; background: #104E8B; border-radius: 10px 10px 10px 10px; margin: 0 0 0 0; padding: 5px 5px; font-weight: bold;"
| style="text-align: center; color: #FFFFFF; font-size: 120%;" | Risk score
|-
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" |'''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" |'''Score'''
! style=" color: #4479BA; background: #FFFFFF; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Variable
! style=" color: #4479BA; background: #FFFFFF; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Score
! style=" color: #4479BA; background: #FFFFFF; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Active [[gastric ulcer|gastric]] or [[duodenal ulcer]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4.5
! style=" color: #FFFFFF; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Active gastric or duodenal ulcer
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Prior [[bleeding]] within the last 3 months|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Thrombocytopenia]] (<50x10<sup>9</sup>/L)|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Age ≥ 85 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Liver failure]] ([[INR]]>1.5)|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Kidney failure|Severe kidney failure]] ([[GFR]]< 30 mL/min/m<sup>2</sup>)|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Admission to [[ICU]] or [[CCU]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Central venous catheter]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Rheumatic disease|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Active [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Age: 40-84 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Male|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Kidney failure|Moderate kidney failure]] ([[GFR]]: 30-59 mL/min/m<sup>2</sup>)|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1
|}
{|
! style="border: 0; float: left; position: float; top: 210px; right: 14px; background: #104E8B; border-radius: 10px 10px 10px 10px; margin: 0 0 0 0; padding: 5px 5px; font-weight: bold; background: #104E8B; color: #FFFFFF; text-align: center;" |Variable
! style="border: 0; float: left; position: float; top: 210px; right: 14px; background: #104E8B; border-radius: 10px 10px 10px 10px; margin: 0 0 0 0; padding: 5px 5px; font-weight: bold; background: #104E8B; color: #FFFFFF; text-align: center;" |Score
! style="border: 0; float: left; position: float; top: 210px; right: 14px; background: #104E8B; border-radius: 10px 10px 10px 10px; margin: 0 0 0 0; padding: 5px 5px; font-weight: bold; background: #104E8B; color: #FFFFFF; text-align: center;" |
|-
|Variable
|Score
|
|-
| style="background: #104E8B; color: #FFFFFF; padding: 2px 10px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |Active gastric or duodenal ulcer
| style="padding: 2px 10px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |4.5
| style="padding: 2px 10px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |4.5
| style="padding: 2px 10px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |  
| style="padding: 2px 10px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" |  

Revision as of 04:52, 26 October 2018


Overview

Project1

Sepsis in Adult Patients

Diagnostic Criteria

  • SIRS
  • Sepsis
  • Severe Sepsis
  • Septic Shock
  • Causes

    Focused Initial Rapid Evaluation

    Empiric Antibiotic Therapy

    Dos

    Don'ts



    Risk score
    Variable Score
    Active gastric or duodenal ulcer 4.5
    Prior bleeding within the last 3 months 4
    Thrombocytopenia (<50x109/L) 4
    Age ≥ 85 years 3.5
    Liver failure (INR>1.5) 2.5
    Severe kidney failure (GFR< 30 mL/min/m2) 2.5
    Admission to ICU or CCU 2.5
    Central venous catheter 2
    Rheumatic disease 2
    Active malignancy 2
    Age: 40-84 years 1.5
    Male 1
    Moderate kidney failure (GFR: 30-59 mL/min/m2) 1

    References